Clinical Trial Update: Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated stereotactic body radiation therapy with 5-fluorouracil or capecitabine for locally advanced pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)

Snippet

Sponsor: University of Nebraska | Conditions: Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING